The use of vasopressin receptor antagonists in hyponatremia

Author： Elhassan Elwaleed A   Schrier Robert W  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.3, 2011-03, pp. : 373-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 249-258

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Vasopressin Receptor Antagonists

By Ali Farhan   Guglin Maya   Vaitkevicius Peter   Ghali Jalal K.  

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 847-858

Adis International

Access to resources Recommend Favorite

Vasopressin receptor antagonists in heart failure

By Thibonnier M.  

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 683-687

Elsevier

Access to resources Recommend Favorite

Specificity of Three Vasopressin Receptor Antagonists

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 6, 2011-07 ,pp. : 529-535

Bentham Science Publishers

Access to resources Recommend Favorite

Vasopressin receptor antagonists in the management of acute heart failure

By Tang WH Wilson   Bhavnani Sanjeev   Francis Gary S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite